Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ondansetron on the incidence of oculocardiac reflex during strabismus surgery
TCTR20250902004Phase 2Recruiting
- Sponsor
- Queen Sirikit National Institute of Child Health
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ondansetron in oculocardiac reflex (OCR), sponsored by Queen Sirikit National Institute of Child Health. Started Aug 2025; status: recruiting.
02
Drugs
ondansetron
03
Conditions
oculocardiac reflex (OCR)
Beyond the preview
Go deeper on TCTR20250902004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250902004.